Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a light hat stop seizures? new study tests infrared therapy

NCT ID NCT07145489

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 39 times

Summary

This pilot study tests whether wearing a hat with infrared lights for 30 minutes each day can reduce seizures in people with drug-resistant epilepsy. The treatment has shown promise in animals but is new for humans. Researchers will track seizure rates and how well people tolerate the daily therapy over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG RESISTANT EPILEPSY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BIDMC

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

infrared light (photobiomodulation) delivered by a hat

What this could lead to

If it works, this could point toward a new, non-invasive way to reduce seizures in people with drug-resistant epilepsy.

What could go wrong

This is a very early, small pilot study with only 13 people. It has not been tested in humans for epilepsy before, so it may not reduce seizures or could be uncomfortable to use daily.

Conditions

The condition(s) this trial relates to.

Drug Resistant Epilepsy epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.